Primary record
2-[(1R,2R,3aS,3bS,9aS,9bR,10S,11aS)-9b-fluoro-1,10-dihydroxy-2,9a,11a-trimethyl-7-oxo-1H,2H,3H,3aH,3bH,4H,5H,7H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-1-yl]-2-oxoethyl hexadecanoate
- 库存
- 2,939 克
- 纯度
- 98.5 %
- CAS
- 14899-36-6
化合物标识与属性
- CAS
- 14899-36-6
- PubChem CID
- 63044
- SMILES
- CCCCCCCCCCCCCCCC(=O)OCC(=O)[C@]1([C@@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2CCC4=CC(=O)C=C[C@@]43C)F)O)C)C)O
- Canonical SMILES
- CCCCCCCCCCCCCCCC(=O)OCC(=O)[C@@]1(O)[C@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C
名称与同义词
- dexamethasone palmitate
- Limethason
- Dexamethasone 21-palmitate
- Limethasone
- Lipotalon
- Cortiject
- 14899-36-6
- 1-Octacosanol
- Limethason (TN)
- DMSP
- Dexamethasone palmitate [JAN]
- RefChem:132373
- dexamethasone 26-palmitate
- D07MME
- C38H59FO6
- AC1L1Y9G
- SCHEMBL93887
- DTXSID8022903
- UNII-601XWN7060
- DEXAMETHASOME PALMITATE
- NOVA63035
- Dexamethasone palmitate (JAN)
- DTXCID202903
- NOVA-63035
- orb1308392
- orb3025698
- 601XWN7060
- CHEBI:31471
- Dexamethasone palmitate, Novagali
- BRN 6031847
- NOVA-22026
- NOVA-22032
- CID63044
- ZINC8214382
- C38-H59-F-O6
- MFCD01698988
- MSK159619
- s5184
- AKOS040741625
- FD21400
- MSK159619-100A
- DEXAMETHASONE PALMITATE [WHO-DD]
- NCGC00522021-01
- DA-62804
- MS-30856
- SY357842
- HY-128922
- J265.157B
- LS-118478
- CS-0102469
- FT-0666305
- D01615
- G13029
- 899D366
- [2-[(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] hexadecanoate
- A1012876
- Q27263139
- 9-Fluoro-11,17-dihydroxy-16-methyl-21-((1-oxohexadecyl)oxy)pregna-1,4-diene-3,20-dione (11beta,16alpha)-
- B0731-059277
- Dexamethasone palmitate Solution in Acetonitrile, 100ug/mL
- Retinopathy therapy (ophthalmic emulsion, Novasorb), Novagali
- Corticosteroid therapy (ophthalmic emulsion, Novasorb), Novagali
- 2-((8S,9R,10S,11S,13S,14S,16R,17R)-9-Fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl palmitate
- 2-[(8S,9R,10S,11S,13S,14S,16R,17R)-9-Fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl Palmitate
- DXP
- Palmitic acid, 21-ester with 9-fluoro-11beta,17,21-trihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione
- Pregna-1,4-diene-3,20-dione, 9-fluoro-11,17-dihydroxy-16-methyl-21-((1-oxohexadecyl)oxy)-, (11beta,16alpha)-
- Pregna-1,4-diene-3,20-dione, 9-fluoro-11-beta,17,21-trihydroxy-16-alpha-methyl-, 21-palmitate
- 9-Fluoro-11beta,17-dihydroxy-16alpha-methyl-3,20-dioxopregna-1,4-dien-21-yl hexadecanoate
- (11|A,16|A)-9-Fluoro-11,17-dihydroxy-16-methyl-21-[(1-oxohexadecyl)oxy]pregna-1,4-diene-3,20-dione
- (11b,16a)-9-Fluoro-11,17-dihydroxy-16-methyl-21-[(1-oxohexadecyl)oxy]pregna-1,4-diene-3,20-dione
- (11beta,16alpha)-9-fluoro-11,17-dihydroxy-16-methyl-3,20-dioxopregna-1,4-dien-21-yl hexadecanoate
- [2-[(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] hexadecanoate
- 2-[(1R,2R,3aS,3bS,9aS,9bR,10S,11aS)-9b-fluoro-1,10-dihydroxy-2,9a,11a-trimethyl-7-oxo-1H,2H,3H,3aH,3bH,4H,5H,7H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-1-yl]-2-oxoethyl hexadecanoate
- 21-(Palmitoyloxy)-9alpha-fluoro-11beta,17alpha-dihydroxy-16alpha-methyl-1,4-pregnadiene-3,20-dione
- 33755-46-3
- 9-FLUORO-11,17-DIHYDROXY-16-METHYL-21-((1- OXOHEXADECYL)OXY)PREGNA-1,4-DIENE-3,20-DIONE (11.BETA.,16.ALPHA.)-
- Pregna-1,4-diene-3,20-dione, 9-fluoro-11,17-dihydroxy-16-methyl-21-[(1-oxohexadecyl)oxy]-, (11beta,16alpha)-
- Pregna-1,4-diene-3,20-dione, 9-fluoro-11-beta,17,21-trihydroxy-16-alpha-methyl-,21-palmitate